Skip to content
DataLookout
Menu

MINSTmelatoninNCT07926282

Adjunctive Melatonin Gel With MINST on GCF Galectin-3 and IL-1 in Stage III-IV Periodontitis

StatusNot Yet Recruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Clinical Attachment Level (CAL)
Timeframe: Baseline, 1 month, and 2 months after treatment
Probing Pocket Depth (PPD)
Timeframe: Baseline, 1 month, and 2 months after treatment
Full-Mouth Plaque Score (FMPS)
Timeframe: Baseline, 1 month, and 2 months after treatment
Full-Mouth Bleeding Score (FMBS)
Timeframe: Baseline, 1 month, and 2 months after treatment
Gingival Recession (GR)
Timeframe: Baseline, 1 month, and 2 months after treatment
Gingival Crevicular Fluid Galectin-3 Level
Timeframe: Baseline, 1 month, and 2 months after treatment
Gingival Crevicular Fluid Interleukin-1 (IL-1) Level
Timeframe: Baseline, 1 month, and 2 months after treatment
Patient Satisfaction
Timeframe: 2 months after treatment

Arms and interventions

MINST + Melatonin GelExperimental

Patients with Stage III-IV periodontitis will receive minimally invasive non-surgical periodontal therapy (MINST) followed by intra-pocket application of melatonin gel once weekly for 4 weeks

MINST AloneActive comparator

Patients with Stage III-IV periodontitis will receive minimally invasive non-surgical periodontal therapy (MINST) only.

Drugs: Melatonin gel

Procedures: Minimally Invasive Non-Surgical Therapy (MINST)